ACCELERON PHARMA INC's ticker is XLRN and the CUSIP is 00434H108. A total of 242 filers reported holding ACCELERON PHARMA INC in Q3 2020. The put-call ratio across all filers is 0.80 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $42,476,000 | +554.3% | 246,814 | +327.8% | 0.03% | +540.0% |
| Q3 2020 | $6,492,000 | +467.0% | 57,691 | +188.5% | 0.01% | +400.0% |
| Q3 2018 | $1,145,000 | -68.6% | 20,000 | -73.4% | 0.00% | -80.0% |
| Q2 2018 | $3,652,000 | +140.9% | 75,248 | +110.7% | 0.01% | +150.0% |
| Q4 2017 | $1,516,000 | -67.6% | 35,712 | -71.5% | 0.00% | -71.4% |
| Q3 2017 | $4,672,000 | +23.3% | 125,208 | +0.4% | 0.01% | 0.0% |
| Q2 2017 | $3,789,000 | – | 124,672 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Darwin Global Management, Ltd. | 938,490 | $120,070,000 | 33.50% |
| Foresite Capital Management III, LLC | 108,630 | $13,898,000 | 16.15% |
| Octagon Capital Advisors LP | 112,363 | $14,376,000 | 4.98% |
| Artal Group S.A. | 1,400,000 | $179,116,000 | 3.84% |
| Avoro Capital Advisors LLC | 1,550,000 | $198,307,000 | 3.42% |
| Affinity Asset Advisors, LLC | 45,000 | $5,757,000 | 3.05% |
| NWI MANAGEMENT LP | 200,000 | $25,588,000 | 2.54% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 71,000 | $9,063,000 | 2.48% |
| FARALLON CAPITAL MANAGEMENT LLC | 2,600,000 | $332,644,000 | 2.00% |
| Parkman Healthcare Partners LLC | 52,458 | $6,711,000 | 1.72% |